发明授权
- 专利标题: Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
- 专利标题(中): 多波坦特成体干细胞,原料为他们获取和保留,分化技术及其使用方法,以及细胞程序从中派生
-
申请号: EP04023157.3申请日: 2002-02-14
-
公开(公告)号: EP1491093B1公开(公告)日: 2013-07-31
- 发明人: Furcht, Leo T. , Verfaillie, Catherine, M. , Reyes, Morayama
- 申请人: ABT Holding Company , Regents of the University of Minnesota
- 申请人地址: 3201 Carnegie Avenue Cleveland, OH 44115 US
- 专利权人: ABT Holding Company,Regents of the University of Minnesota
- 当前专利权人: ABT Holding Company,Regents of the University of Minnesota
- 当前专利权人地址: 3201 Carnegie Avenue Cleveland, OH 44115 US
- 代理机构: Cornish, Kristina Victoria Joy
- 优先权: US268786P 20010214; US269062P 20010215; US310625P 20010807; US343836P 20011025
- 主分类号: A01N63/00
- IPC分类号: A01N63/00
摘要:
An isolated multipotent adult stem cell (MASC), which has the capacity to be induced to differentiate to form at least one differentiated cell type of mesodermal, ectodermal or endodermal origin, is new. Independent claims are also included for: (1) creating (M1) a normal non-human animal; (2) compositions comprising: (a) a population of MASC and a medium, where the culture medium expands the MASC; or (b) a population of fully or partially purified MASC progeny; (3) isolating (M2) and propagating the MASC; (4) an expanded MASC population obtained by (M2); (5) differentiating (M3) MASC ex vivo or in vivo; (6) differentiated cells obtained by (M3); (7) a therapeutic composition comprising MASC and a pharmaceutical carrier, where the MASC are present in to produce bone marrow, blood, spleen, liver, lung, intestinal tract, eye, brain, immune system, bone, connective tissue, muscle, heart, blood vessels, pancreas, central nervous system, kidney, bladder, skin, epithelial appendages, breast-mammary gland, fat or mucosal surface (e.g. oral, esophageal, vaginal or anal) tissues; (8) restoring (M4) organ tissue or cellular function to a patient; (9) inhibiting (M5) the rejection of a heterologous MASC transplanted into a patient; (10) generating (M6) blood or individual blood components ex vivo; (11) drug discovery; (12) identifying (M7) the components of a differentiation pathway; (13) comparing (M8) differentiation in vitro with differentiation in vivo by comparing the results obtained in (M7); (14) identifying (M9) the molecular components of disease or injury; (15) generating (M10) products (which have therapeutic, diagnostic or research utility) in vitro; (16) inducing (M11) in a mammal, tolerance to an antigen administered to the mammal; (17) removing (M12) toxins from the blood of a patient; (18) delivering (M13) therapeutic products to a patient; and (19) testing (M14) the toxicity of a drug. ACTIVITY : Cytostatic; Cardiant; Cardiovascular; Hepatotropic; Hemostatic; Antidiabetic; Virucide; Anti-inflammatory; Vasotropic; Neuroprotective; Antianemic; Cerebroprotective; Immunosuppressant; Antibacterial. No biological data given. MECHANISM OF ACTION : Cell Replacement Therapy.
公开/授权文献
信息查询